Clinical features of idiopathic restrictive cardiomyopathy: A retrospective multicenter cohort study over 2 decades

Medicine (Baltimore). 2017 Sep;96(36):e7886. doi: 10.1097/MD.0000000000007886.

Abstract

Idiopathic restrictive cardiomyopathy (RCMP) has not been fully understood because this disease is difficult to diagnose. The present study aimed to assess the clinical profile and outcome of idiopathic RCMP from a multicenter cohort.This investigation is a retrospective study of consecutive patients with idiopathic RCMP at 10 centers in Korea between 1990 and 2010. We evaluated the clinical characteristics of the patients and prognostic factors associated with mortality using multivariate Cox proportional hazards regression analyses.The study included 53 patients (26 men, 49.1%). During a median follow-up of 1.7 years, 17 patients (32.1%) died and 5 patients (9.4%) received a heart transplant. The 5-year survival rate of the overall patients was 64.4% ± 7.8%. In multivariable analyses, the predictors of mortality were tricuspid regurgitation (TR) ≥ moderate (hazard ratio [HR] 32.55, P < .001) and left ventricular end-diastolic diameter (LVEDD) (HR 0.85, P < .001).Idiopathic RCMP showed unfavorable prognosis. Advanced TR and lower LVEDD are independent adverse predictors of mortality in patients with idiopathic RCMP.

Publication types

  • Multicenter Study

MeSH terms

  • Cardiomyopathy, Restrictive / diagnosis
  • Cardiomyopathy, Restrictive / mortality*
  • Cardiomyopathy, Restrictive / physiopathology
  • Cardiomyopathy, Restrictive / therapy*
  • Female
  • Follow-Up Studies
  • Heart Transplantation / statistics & numerical data
  • Heart Ventricles / diagnostic imaging
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Organ Size
  • Prognosis
  • Proportional Hazards Models
  • Republic of Korea
  • Retrospective Studies
  • Survival Analysis
  • Tricuspid Valve Insufficiency / diagnosis
  • Tricuspid Valve Insufficiency / mortality
  • Tricuspid Valve Insufficiency / physiopathology
  • Tricuspid Valve Insufficiency / therapy